MMG
LGND icon

Monetary Management Group’s Ligand Pharmaceuticals LGND Stock Holding History

Monetary Management Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,504
Closed -$528K – 316
2020
Q4 		$528K Hold
8,504
– – 0.17% 104
2020
Q3 		$506K Sell
8,504
-240
-3% -$16.4K 0.18% 106
2020
Q2 		$610K Buy
8,744
+7,750
+780% +$491K 0.23% 87
2020
Q1 		$45K Hold
994
– – 0.02% 202
2019
Q4 		$65K Buy
+994
New +$66.4K 0.02% 213
2017
Q1 		– Sell
-160
Closed -$10K – 306
2016
Q4 		$10K Sell
160
-161
-50% -$10.2K ﹤0.01% 302
2016
Q3 		$20K Buy
+321
New +$23.6K 0.01% 274

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Monetary Management Group's LGND Position: Q1 2021 in Review

Monetary Management Group sold out of Ligand Pharmaceuticals (LGND) in Q1 2021, closing a stake of 8,504 shares — an estimated $528K sold.

Monetary Management Group first reported a position in LGND in Q3 2016 and held it in 7 quarters. The position peaked at $610K in Q2 2020. 228 funds tracked by Wall St. Rank hold LGND as of Q1 2021.

  • Monetary Management Group reported no remaining Ligand Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Monetary Management Group sold 8,504 Ligand Pharmaceuticals shares in Q1 2021, an estimated $528K.
  • Monetary Management Group first reported a position in Ligand Pharmaceuticals in Q3 2016 and held it in 7 quarters.
  • Monetary Management Group's Ligand Pharmaceuticals position peaked at $610K in Q2 2020.
  • 228 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2021.

Based on Monetary Management Group's 13F filing for Q1 2021, filed 17 May 2021.